在3月18日的港股市场中，恒生科技指数和恒生指数双双高开，分别上涨超过3%和2.1%。医疗保健行业表现尤为突出，其中港股创新药ETF（159567）盘中涨幅逾4%，并且其换手率达到20%之高，显示出投资者对该板块的强烈关注。成分股方面，药明康德实现了 ...

StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note released on Sunday. The firm issued a sell rating on the stock. Trinity Biotech Trading Down ...

相关ETF方面， 港股创新药ETF（159567） 盘中涨逾4%，换手率超20%。成分股方面，药明康德一度涨超15%，现涨13.3%，药明合联、药明生物涨幅随后，康诺亚-B、乐普生物-B等多股涨超5%。

今日港股集体回调，港股通创新药ETF（159570）逆市飘红涨超2%，成交额1.6亿元，近20日获得资金大举净流入近6.5亿元，一个月规模翻倍！港股通创新药ETF（159570）成分股多数飘红：和黄医药绩后涨超9%，三生制药涨超6%，百济神州涨超2% ...

今日A股集体走高，医药板块强势，CXO一马当先。生物药ETF(159839)盘中涨2%，冲击3连涨，盘中价刷新年内新高！消息面上，生物药ETF(159839)标的指数成份股——药明康德3月17日发布2024年财报，第四季度收入增至115.4亿元，强势 ...

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. The ETF industry ...

PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 26,800 shares ...

The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.